The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip ... vascular access, infusion therapy, hemodialysis, non-vascular, urology, and ...

Venova Medical recently announced the enrollment of the first patients in the company’s VENOS-2 early feasibility study o ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

January 15, 2025—Radical Catheter Technologies announced it has received FDA 510(k) clearance for the company’s 8-F Radical neurovascular catheter. Built on the same platform as Radical’s FDA-cleared ...

The effectiveness of alteplase and urokinase in restoring adequate hemodialysis blood-flow rates was examined. A retrospective review of the medical records of hemodialysis patients with central ...

The Chief Electoral Officer, Delhi, is conducting a Special Summary Revision of electoral rolls with the qualifying date set as January 1, 2025, a statement said on Tuesday, highlighting the CEO's ...

SEATTLE – As Tahlequah carries her dead calf, scientists studying the endangered southern residents are concerned for the mother orca. On Christmas Eve it was confirmed she gave birth to a ...

India are all set to face Australia in the highly-anticipated Boxing Day Test from Thursday at the Melbourne Cricket Ground (MCG). This will be the fourth Test of the five-match Border-Gavaskar ...

Before 1998, urokinase was considered standard therapy for the management of occluded hemodialysis catheters. The dose of 5000 units per port appears on the FDA-approved labeling for urokinase.

“From ventilators and neonatal breathing tubes to hemodialysis catheters, the scarcity of these critical devices poses a growing threat to patient care—especially for our youngest and most ...